• Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases

  • Jul 29 2021
  • Duración: 21 m
  • Podcast

Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases Por arte de portada

Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this podcast, we invite two authors from recent ARD papers dedicated to the efficacy of mRNA vaccines in patients with immunosuppressive therapies. Christophe Richez, Department of Rheumatology, University Medical Center, Bordeaux, France, and ARD's Social Media Advisor, interviews Bimba Hoyer, Department for Rheumatology and Clinical Immunology, University Medical Center Schleswig-Holstein Campus Kiel, Germany, and Rebecca H Haberman, Division of Rheumatology, University Grossman School of Medicine, New York, USA. They describe their works and offer their thoughts on the current situation in this area and the future. Related content: https://ard.bmj.com/content/early/2021/05/11/annrheumdis-2021-220272

    https://ard.bmj.com/content/early/2021/06/07/annrheumdis-2021-220597
    Más Menos
activate_primeday_promo_in_buybox_DT
Enfermedades Físicas Hygiene & Healthy Living
Más Menos

Lo que los oyentes dicen sobre Immunogenicity of anti-SARS-CoV-2 mRNA vaccines in patients with rheumatic diseases

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles